What's this about? More info here.
Crinetics Pharma’s Promising Study on CRN04894 for Cushing’s Syndrome: A
Potential Game-Changer?
-
Crinetics Pharmaceuticals is conducting a study titled ‘A Phase 1b/2a
Open-label Multiple-ascending Dose Exploratory Study of CRN04894 in
ACTH-dependent Cu...
1 day ago


